Table 1.
Baseline characteristics of 108 patients before percutaneous transhepatic biliary drainage
Characteristics | Value | |
---|---|---|
Age (years), mean (SD), n (%) | 61.7 ±10.9 | |
> 70 years | 28 (25.9) | |
≤ 70 years | 80 (74.1) | |
Sex, male/female | 72/36 | |
ECOG performance status, n (%) | ||
1 | 18 (16.7) | |
2 | 50 (46.3) | |
3 | 26 (24.1) | |
4 | 14 (12.9) | |
Tumour type, n (%) | ||
Pancreatic carcinoma | 34 (31.5) | |
Cholangiocarcinoma | 20 (18.5) | |
Hepatocellular carcinoma | 20 (18.5) | |
Digestive tract invasion | 11 (10.2) | |
Gallbladder carcinoma | 9 (8.3) | |
Lymph node metastasis | 8 (7.4) | |
Other | 6 (5.6) | |
Obstruction level, n (%) | ||
Hilar | 27 (25) | |
Non-hilar | 81 (75) | |
Liver metastases, n (%) | ||
Present | 35 (32.4) | |
Absent | 73 (67.6) | |
Serum bilirubin level prior to PTBD, n (%) | ||
> 342 µmol/l | 43 (39.8) | |
≤ 342 µmol/l | 65 (61.2) | |
Duration from onset of jaundice to PTBD, days, median (IQR) | 16 (8.5-23) | |
Hospital stay, days, median (IQR) | 9 (4-17) |
ECOG – Eastern Cooperative Oncology Group; PTBD – percutaneous transhepatic biliary drainage